Why does gene therapy using engineered mature T-lymphocytes for ADA deficiency require periodic, repeated infusions rather than providing a permanent cure?

Answer and explanation

Correct answer: A. Because mature human T-lymphocytes are mortal and have a finite lifespan in the blood

  1. Step 1: In the lymphocyte infusion procedure, mature circulating T-cells are harvested and transduced in culture.
  2. Step 2: Fully differentiated mature lymphocytes are somatic cells with a natural lifespan of a few months.
  3. Step 3: When these cells undergo apoptosis, the therapeutic gene is lost, requiring lifelong periodic infusions; a permanent cure can only be achieved if the functional gene is introduced into immortal pluripotent hematopoietic stem cells at early embryonic stages.
Answer
Because mature human T-lymphocytes are mortal and have a finite lifespan in the blood.
Why not the others: The retroviral vector stably integrates as a provirus and does not continuously mutate; Patients do not reject the self-antigen enzyme; Integrated proviruses replicate with host DNA and are not degraded.

Practise more Biotechnology: Principles and Applications.

Free questions with an explanation for every one, and full timed NEET UG mock tests.

Why does gene therapy using engineered mature… | NEET UG